Granted Patent
B2
US 11,752,149 · App. 17/103,455 · Granted Sep 12, 2023
Muscarinic acetylcholine M1 receptor antagonists
Inventors:
Yifeng Xiong (San Diego, CA); Jeffrey Roppe (Temecula, CA); Austin Chih-Yu Chen (San Diego, CA); Yalda Bravo (San Diego, CA); Thomas Schrader (San Diego, CA); Jill Melissa Baccei (San Diego, CA)
Assignee:
Pipeline Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
Claims (3)
1. A compound selected from:
or a pharmaceutically acceptable salt or solvate thereof.
2. A pharmaceutical composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt or solvate thereof, and at least one pharmaceutically acceptable excipient.
Assignments (2)
CHANGE OF NAME
Recorded Jan 18, 2024
From: PIPELINE THERAPEUTICS, INC.
To: CONTINEUM THERAPEUTICS, INC.
Reel/Frame 066353/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 31, 2021
From: XIONG, YIFENG; ROPPE, JEFFREY; CHEN, AUSTIN CHIH-YU; BRAVO, YALDA; SCHRADER, THOMAS; BACCEI, JILL MELISSA
To: PIPELINE THERAPEUTICS, INC.
Reel/Frame 055787/0084 →
Continuity (2)
Provisional Application
62942665
· Dec 2, 2019
Cited By (2)